NCT02849210View on ClinicalTrials.gov

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 2, 2017

Study Completion Date

June 2, 2017

Conditions

Rhinoconjunctivitis

Interventions

BIOLOGICAL

Allergovac depot with Olea europaea pollen extract

Subcutaneous immunotherapy in depot presentation in a rapid dose escalation scheme: 6 weekly increasing dose injections at the initiation phase plus 3 maintenance monthly injections.

Trial Locations (5)

23007

Complejo Hospitalario de Jaén, Jaén

Unknown

Hospital Santa Bárbara, Puertollano

Hospital Infanta Cristina, Badajoz

Hospital Costa de la Luz, Huelva

Hospital Nisar Sevilla, Seville

All Listed Sponsors

lead

Roxall Medicina España S.A

INDUSTRY

NCT02849210 - A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea | Biotech Hunter | Biotech Hunter